Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Taguchi

Showing results (111-120 of 154) with videos related to

Pageof 16
Sort By:
International Journal of Hematology|October 21, 2020
Correction to: Programmed death 1 ligand (PD-L1) in solid cancers after allogeneic hematopoietic stem cell transplantation: a retrospective analysis by the Nagasaki Transplant GroupSachie Kasai, Hidehiro Itonaga, Daisuke Niino, et al.
Internal Medicine (Tokyo, Japan)|September 4, 2018
Primary Oral Mucormycosis Due to Rhizopus microsporus after Allogeneic Stem Cell TransplantationHikaru Sakamoto, Hidehiro Itonaga, Yasushi Sawayama, et al.
Japanese Journal of Clinical Oncology|May 28, 2025
Prognostic factors and overall survival for recurrent and metastatic head and neck squamous cell carcinoma: a multicenter retrospective analysisKazufumi Obata, Satoshi Kano, Akira Ohkoshi, et al.
International Journal of Hematology|December 26, 2006
Human herpesvirus 6 meningoencephalitis in allogeneic hematopoietic stem cell transplant recipientsKatsumichi Fujimaki, Takehiko Mori, Aiko Kida, et al.
Cancer Medicine|January 17, 2020
A multicenter phase II trial of paclitaxel, carboplatin, and cetuximab followed by chemoradiotherapy in patients with unresectable locally advanced squamous cell carcinoma of the head and neckTomohiro Enokida, Takenori Ogawa, Akihiro Homma, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|September 3, 2013
Standard R-CHOP therapy in follicular lymphoma and diffuse large B-cell lymphomaNaoto Tomita, Hirotaka Takasaki, Shin Fujisawa, et al.
Leukemia Research|June 1, 2016
Acute megakaryoblastic leukemia, unlike acute erythroid leukemia, predicts an unfavorable outcome after allogeneic HSCTKen Ishiyama, Takuhiro Yamaguchi, Tetsuya Eto, et al.
EJNMMI Research|July 17, 2023
Early prediction of treatment outcome for lenvatinib using <sup>18</sup>F-FDG PET/CT in patients with unresectable or advanced thyroid carcinoma refractory to radioiodine treatment: a prospective, multicentre, non-randomised studySatoshi Takeuchi, Kenji Hirata, Keiichi Magota, et al.
American Journal of Hematology|December 23, 2014
Shorter halving time of BCR-ABL1 transcripts is a novel predictor for achievement of molecular responses in newly diagnosed chronic-phase chronic myeloid leukemia treated with dasatinib: Results of the D-first study of Kanto CML study groupNoriyoshi Iriyama, Shin Fujisawa, Chikashi Yoshida, et al.
International Journal of Hematology|January 23, 2017
Body mass index is a prognostic factor in adult patients with acute myeloid leukemiaTaiki Ando, Etsuko Yamazaki, Eriko Ogusa, et al.
Pageof 16

Showing results (111-120 of 154) with videos related to

Sort By:
Pageof 16
International Journal of Hematology|October 21, 2020
Correction to: Programmed death 1 ligand (PD-L1) in solid cancers after allogeneic hematopoietic stem cell transplantation: a retrospective analysis by the Nagasaki Transplant GroupSachie Kasai, Hidehiro Itonaga, Daisuke Niino, et al.
Internal Medicine (Tokyo, Japan)|September 4, 2018
Primary Oral Mucormycosis Due to Rhizopus microsporus after Allogeneic Stem Cell TransplantationHikaru Sakamoto, Hidehiro Itonaga, Yasushi Sawayama, et al.
Japanese Journal of Clinical Oncology|May 28, 2025
Prognostic factors and overall survival for recurrent and metastatic head and neck squamous cell carcinoma: a multicenter retrospective analysisKazufumi Obata, Satoshi Kano, Akira Ohkoshi, et al.
International Journal of Hematology|December 26, 2006
Human herpesvirus 6 meningoencephalitis in allogeneic hematopoietic stem cell transplant recipientsKatsumichi Fujimaki, Takehiko Mori, Aiko Kida, et al.
Cancer Medicine|January 17, 2020
A multicenter phase II trial of paclitaxel, carboplatin, and cetuximab followed by chemoradiotherapy in patients with unresectable locally advanced squamous cell carcinoma of the head and neckTomohiro Enokida, Takenori Ogawa, Akihiro Homma, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|September 3, 2013
Standard R-CHOP therapy in follicular lymphoma and diffuse large B-cell lymphomaNaoto Tomita, Hirotaka Takasaki, Shin Fujisawa, et al.
Leukemia Research|June 1, 2016
Acute megakaryoblastic leukemia, unlike acute erythroid leukemia, predicts an unfavorable outcome after allogeneic HSCTKen Ishiyama, Takuhiro Yamaguchi, Tetsuya Eto, et al.
EJNMMI Research|July 17, 2023
Early prediction of treatment outcome for lenvatinib using <sup>18</sup>F-FDG PET/CT in patients with unresectable or advanced thyroid carcinoma refractory to radioiodine treatment: a prospective, multicentre, non-randomised studySatoshi Takeuchi, Kenji Hirata, Keiichi Magota, et al.
American Journal of Hematology|December 23, 2014
Shorter halving time of BCR-ABL1 transcripts is a novel predictor for achievement of molecular responses in newly diagnosed chronic-phase chronic myeloid leukemia treated with dasatinib: Results of the D-first study of Kanto CML study groupNoriyoshi Iriyama, Shin Fujisawa, Chikashi Yoshida, et al.
International Journal of Hematology|January 23, 2017
Body mass index is a prognostic factor in adult patients with acute myeloid leukemiaTaiki Ando, Etsuko Yamazaki, Eriko Ogusa, et al.
Pageof 16